Zimmermann Martine — SEC Form 4 filings
SEC reporting owner CIK 1994049. 6 Form 4 filings on record with FilingPulse; latest filed 2026-09-14.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-06-18 to 2026-09-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 1,200 shares, $342,000 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 1,200 shares @ $285.00 ($342,000) in LIGAND PHARMACEUTICALS INC, filed 2026-09-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| LIGAND PHARMACEUTICALS INC (LGND) | Director | 5 | — | 1 leg · 1,200 sh · $342,000 | 9 |
| Candel Therapeutics, Inc. (CADL) | Director | 1 | — | — | 1 |
Form 4 filings — Zimmermann Martine
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-14 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Sale (S): 1,200 @ $285 | EDGAR |
| 2026-09-10 | 4 | Candel Therapeutics, Inc. (CADL) | Grant/award (A): 64,000 (derivative) @ $0 | EDGAR |
| 2026-06-09 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Grant/award (A): 836 @ $0 · Tax withholding (F): 182 @ $237 · Grant/award (A): 2,938 (derivative) @ $0 | EDGAR |
| 2025-09-24 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Tax withholding (F): 115 @ $170.77 | EDGAR |
| 2025-06-10 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Grant/award (A): 1,209 @ $0 · Tax withholding (F): 188 @ $105.99 · Grant/award (A): 5,783 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Grant/award (A): 1,252 @ $0 · Grant/award (A): 5,444 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1994049 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →